Exploring the Mechanism of Chuanxiong Rhizoma against Thrombosis Based on Network Pharmacology, Molecular Docking and Experimental Verification.

He, Shasha; He, Xuhua; Pan, Shujuan; Jiang, Wenwen

He, Shasha; He, Xuhua; Pan, Shujuan; Jiang, Wenwen.

Afiliación

He S; School of Pharmacy, Guizhou University, Guiyang 550025, China.
He X; School of Pharmacy, Guizhou University, Guiyang 550025, China.
Pan S; School of Pharmacy, Guizhou University, Guiyang 550025, China.
Jiang W; Engineering Research Center of the Utilization for Characteristic Bio-Pharmaceutical Resources in Southwest, Ministry of Education, Guizhou University, Guiyang 550025, China.

Molecules ; 28(18)2023 Sep 19.

Article en En | MEDLINE | ID: mdl-37764479

Asunto(s)

Farmacología en Red; Trombosis; Humanos; Simulación del Acoplamiento Molecular; Fosfatidilinositol 3-Quinasas; Trombosis/tratamiento farmacológico; Coagulación Sanguínea

Palabras clave

Chuanxiong rhizoma; PI3K/Akt/NF-κB signaling pathway; anti-thrombosis; ligustilide; network pharmacology; tissue factor

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trombosis / Farmacología en Red Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Molecules Asunto de la revista: BIOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: China

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google